Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Salicylic Augmentation in Depression
Phase 2
Terminated
- Conditions
- DepressionTreatment Resistant DepressionDepressive DisorderMajor Depressive Disorder
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Jessica Harder
- Target Recruit Count
- 32
- Registration Number
- NCT03152409
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
News
No news found